pyrroles has been researched along with Rheumatism in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (44.83) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Bajocchi, G; Beltrami, M; Boiardi, L; Cassone, G; Catanoso, M; Cimino, L; Costantini, M; Croci, S; Di Lernia, V; Dolci, G; Galli, E; Giorgi Rossi, P; Girolimetto, N; Gradellini, F; Mancuso, P; Marata, AM; Massari, M; Muratore, F; Pipitone, N; Salvarani, C | 1 |
| Charles-Schoeman, C; Cohen, S; Connell, C; Curtis, JR; Fallon, L; Graham, D; Greenberg, J; Hauben, M; Hung, E; Jones, TV; Kanik, KS; Kremer, J; Madsen, A; Malley, W; Mease, P; Onofrei, A; Valdez, H; Wang, C; Woolcott, J; Yun, H | 1 |
| Abdel, MP; Brause, B; Chen, AF; Dasa, V; George, M; Gewurz-Singer, O; Giles, JT; Gililland, J; Goodman, M; Goodman, SM; Guyatt, G; Hurley-Rosenblatt, A; Johnson, B; Kirou, K; Lee, S; Losina, E; MacKenzie, R; Mandl, LA; Michaud, K; Mikuls, T; Miller, AS; Mont, MA; Russell, L; Sah, A; Sculco, P; Singh, JA; Sporer, S; Springer, B; Stryker, L; Turgunbaev, M; Yates, A | 2 |
| Accossato, P; Choy, E; DeMasi, R; Kola, B; Lula, S; Nurmohamed, M | 1 |
| Simmons, DL | 1 |
| So, A; Varisco, PA | 1 |
| Harada, T; Nakamura, H | 1 |
| Croasdell, G; Walker, G | 1 |
| Friedman, MA; Winthrop, KL | 1 |
| Winthrop, KL | 1 |
| Ostermeier, E; Roll, P; Tony, HP | 1 |
| Abud-Mendoza, C; Baranda, L; Cruz-Rizo, J; Cuevas-Orta, E; de la Fuente, H; González-Amaro, R | 1 |
| Bielinska, A; Gluszko, P | 1 |
| Paulus, HE | 1 |
| Bertelletti, D; Cioffi, T; Guslandi, M; Sarchi, C | 1 |
| Donati, G; Spinazzè, R | 1 |
| Wauters, M | 2 |
| Lewis, JR | 1 |
| Avery, GS; Brogden, RN; Heel, RC; Speight, TM | 1 |
| Chlud, K; Kaik, B | 1 |
| Weissenbach, R | 1 |
| Chantraine, A; Gustin, R | 1 |
| Maibach, E | 1 |
| Diverse, P | 1 |
| Famaey, JP | 1 |
| Bahous, I | 1 |
9 review(s) available for pyrroles and Rheumatism
| Article | Year |
|---|---|
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Elective Surgical Procedures; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Perioperative Care; Piperidines; Pyrimidines; Pyrroles; Rheumatic Diseases; Rheumatology; Spondylarthritis; Spondylitis, Ankylosing; Surgeons; United States | 2017 |
The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review.
Topics: Animals; Antirheumatic Agents; Biological Products; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Piperidines; Prospective Studies; Pyrimidines; Pyrroles; Retrospective Studies; Rheumatic Diseases; Risk Factors | 2018 |
Targeting kinases: a new approach to treating inflammatory rheumatic diseases.
Topics: Animals; Humans; Intracellular Signaling Peptides and Proteins; Janus Kinase 3; Mitogen-Activated Protein Kinases; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Rheumatic Diseases; Syk Kinase | 2013 |
[Pharmacology profile and clinical findings of tofacitinib citrate (Xeljanz® tablet 5 mg)].
Topics: Administration, Oral; Animals; Humans; Mice; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Rats; Rheumatic Diseases | 2014 |
Vaccines and Disease-Modifying Antirheumatic Drugs: Practical Implications for the Rheumatologist.
Topics: Abatacept; Antirheumatic Agents; Contraindications; Drug Interactions; Herpes Zoster Vaccine; Humans; Immunocompromised Host; Immunogenicity, Vaccine; Influenza Vaccines; Methotrexate; Piperidines; Pneumococcal Vaccines; Pyrimidines; Pyrroles; Rheumatic Diseases; Rheumatologists; Rituximab; Vaccines; Vaccines, Attenuated; Yellow Fever Vaccine | 2017 |
The emerging safety profile of JAK inhibitors in rheumatic disease.
Topics: Azetidines; Humans; Infections; Janus Kinases; Neoplasms; Piperidines; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyrimidines; Pyrroles; Rheumatic Diseases; Signal Transduction; Sulfonamides | 2017 |
[Statins--are they potentially useful in rheumatology?].
Topics: Arthritis, Rheumatoid; Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lupus Erythematosus, Systemic; Osteoporosis; Pyrroles; Rheumatic Diseases; Simvastatin; Treatment Outcome | 2007 |
ML 3000.
Topics: Acetates; Animals; Clinical Trials as Topic; Drug Industry; Humans; Lung Diseases, Obstructive; Pyrroles; Rheumatic Diseases | 2002 |
Tolmetin: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Arthritis, Rheumatoid; Blood Platelets; Endocrine Glands; Humans; Intestinal Absorption; Intestinal Mucosa; Kinetics; Osteoarthritis; Prostaglandin Antagonists; Pyrroles; Rats; Rheumatic Diseases; Skin Tests; Spondylitis, Ankylosing; Tolmetin | 1978 |
7 trial(s) available for pyrroles and Rheumatism
| Article | Year |
|---|---|
Therapy with statins in patients with refractory rheumatic diseases: a preliminary study.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Atorvastatin; Biomarkers; Blood Sedimentation; C-Reactive Protein; Child; Chloroquine; Dose-Response Relationship, Drug; Granulomatosis with Polyangiitis; Heptanoic Acids; HLA-DR Antigens; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Middle Aged; Proteinuria; Pyrroles; Rheumatic Diseases; Rheumatic Fever; Simvastatin; Treatment Outcome | 2003 |
[A clinical study to determine the optimal dosage of ST-679 in the treatment of rheumatic diseases].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Dose-Response Relationship, Drug; Drug Tolerance; Female; Glycine; Humans; Male; Middle Aged; Pyrroles; Rheumatic Diseases | 1993 |
Clinical studies of the interaction between tolmetin and glibenclamide.
Topics: Adult; Aged; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Drug Interactions; Female; Glyburide; Glycosuria; Humans; Middle Aged; Pyrroles; Rheumatic Diseases; Time Factors; Tolmetin | 1977 |
[Clinical study with 1-parachlorophenyl-2,5-dimethylpyrroleacetic acid--clopirac (author's transl)].
Topics: Adult; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Osteoarthritis; Pyrroles; Rheumatic Diseases | 1975 |
[Clinical study of clopirac in osteoarthritis and non articular rheumatisms (author's transl)].
Topics: Arthritis; Clinical Trials as Topic; Humans; Osteoarthritis; Pyrroles; Rheumatic Diseases | 1975 |
[Clinical trial of 1-p-chlorophenyl-2,5-dimethyl-3-pyrrole acetic acid (clopiran) (author's transl)].
Topics: Clinical Trials as Topic; Female; Humans; Male; Osteoarthritis; Pyrroles; Rheumatic Diseases; Wounds and Injuries | 1975 |
European experiences with tolmetin in the treatment of rheumatic diseases.
Topics: Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Female; Humans; Indomethacin; Male; Middle Aged; Osteoarthritis; Oxyphenbutazone; Placebos; Pyrroles; Rheumatic Diseases; Tolmetin; Wounds and Injuries | 1976 |
13 other study(ies) available for pyrroles and Rheumatism
| Article | Year |
|---|---|
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study.
Topics: Abatacept; Adult; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azetidines; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Susceptibility; Female; Hospitalization; Humans; Interleukin 1 Receptor Antagonist Protein; Italy; Janus Kinase Inhibitors; Logistic Models; Male; Middle Aged; Pandemics; Piperidines; Pneumonia, Viral; Proportional Hazards Models; Purines; Pyrazoles; Pyrimidines; Pyrroles; Rheumatic Diseases; Risk Factors; SARS-CoV-2; Severity of Illness Index; Sulfonamides; Tumor Necrosis Factor Inhibitors; Ustekinumab | 2020 |
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
Topics: Adult; Aged; Antirheumatic Agents; Clinical Trials as Topic; Female; Humans; Incidence; Male; Middle Aged; Observational Studies as Topic; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Rheumatic Diseases; Thromboembolism | 2020 |
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biological Products; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Orthopedics; Perioperative Care; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Rheumatic Diseases; Rheumatology; Societies, Medical; Spondylitis, Ankylosing; United States | 2017 |
[A new therapeutical option for chronic inflammation in rheumatology: janus kinases inhibitors (JAK)].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chronic Disease; Drug Approval; Humans; Inflammation; Janus Kinases; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Rheumatic Diseases; Switzerland | 2014 |
The European League Against Rheumatism (EULAR) - 17th Annual European Congress of Rheumatology (June 8-11, 2016 - London, UK).
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Humans; Piperidines; Pyrimidines; Pyrroles; Rheumatic Diseases; Rheumatology | 2016 |
[Janus kinase inhibitors].
Topics: Antirheumatic Agents; Drug Delivery Systems; Humans; Janus Kinases; Piperidines; Pyrimidines; Pyrroles; Rheumatic Diseases | 2012 |
Government affairs. FDA Arthritis Advisory Committee Meeting.
Topics: Anaphylaxis; Drug Evaluation; Humans; Ibuprofen; Palliative Care; Pyrroles; Rheumatic Diseases; Tolmetin | 1983 |
Tolmetin sodium in clinical practice: a survey of 32,207 treated patients.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Female; Humans; Male; Middle Aged; Pyrroles; Rheumatic Diseases; Tolmetin | 1981 |
[Studies of the therapeutic effectiveness of clopirac in non articular rheumatism (author's transl)].
Topics: Back Pain; Humans; Neuralgia; Periarthritis; Pyrroles; Rheumatic Diseases; Sciatic Nerve; Tendinopathy | 1975 |
New antirheumatic agents: Fenoprofen calcium (Nalfon), naproxen (Naprosyn), and tolmetin sodium (Tolectin).
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Fenoprofen; Gastrointestinal Hemorrhage; Humans; Naphthaleneacetic Acids; Naproxen; Osteoarthritis; Phenylpropionates; Pyrroles; Rheumatic Diseases; Spondylitis, Ankylosing; Tolmetin | 1977 |
[Clopirac effectiveness in traumatology and non articular rheumatisms (author's transl)].
Topics: Adult; Female; Humans; Inflammation; Ligaments, Articular; Male; Middle Aged; Postoperative Complications; Pyrroles; Rheumatic Diseases | 1975 |
[Open study of clopirac in the treatment of non articular rheumatism (author's transl)].
Topics: Adult; Female; Humans; Male; Middle Aged; Periarthritis; Pyrroles; Rheumatic Diseases; Tendinopathy | 1975 |
[Clinical experiences with tolectin in rheumatic diseases (author's transl)].
Topics: Drug Evaluation; Female; Humans; Male; Middle Aged; Pyrroles; Rheumatic Diseases; Tolmetin | 1976 |